Press release
Visceral Pain Associated with GI Disorders Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies-AstraZeneca, Roche
(Las Vegas, Nevada, United States), DelveInsight's "Visceral Pain associated with GI disorders Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Visceral Pain associated with GI disorders, historical and forecasted epidemiology as well as the Visceral Pain associated with GI disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.Download Sample Report to know more:
https://www.delveinsight.com/sample-request/visceral-pain-associated-with-gi-disorders-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr.
Visceral Pain Associated with GI Disorders Overview
With Visceral Pain Associated with GI Disorders, the cancer stops responding to hormone treatment, and it is found in other parts of the body. It can spread to nearby lymph nodes, bones, the bladder, , liver, lungs, and maybe the brain.
Click here to learn more about the Visceral Pain Associated with GI Disorders Market Landscape @ https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlight from Visceral Pain Associated with GI Disorders Market Report
Key Companies working in Visceral Pain Associated with the GI Disorders market include
AstraZeneca
Roche Pharmaceuticals
Janssen Pharmaceuticals
And many others.
Key Therapies working in Visceral Pain associated with GI Disorders market include
Atezolizumab
SXL-01
The annual incidence of mCRPC: is 21 per 100 000 men whereas the prevalence of mCRPC: is 62 per 100 000 men.
Visceral Pain Associated with GI Disorders Treatment Market
The chemotherapy drugs most commonly used are docetaxel with prednisone. But if docetaxel and prednisone are no longer working, you may be given cabazitaxel (Jevtana) or mitoxantrone. Other chemotherapy drugs that may be used include paclitaxel.
Learn more about the treatment market for Visceral Pain Associated with GI Disorders @https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr.
The Report Covers the Visceral Pain Associated with GI Disorders Epidemiology Segmented by:
Visceral Pain Associated with GI Disorders prevalent cases
Visceral Pain Associated with GI Disorders Incident Cases
Visceral Pain Associated with GI Disorders Treatment cases
Visceral Pain Associated with GI Disorders Diagnosed cases
Visceral Pain Associated with GI Disorders Dug Profile and Companies Covered
AstraZeneca- SXL01
Janssen Pharmaceuticals- Docetaxel
Tomopath Inc- Atezolizumab
Roche Pharmaceuticals- Ipatasertib
And many others
Learn more about the Key Companies and Emerging Therapies in the Hemophilia Market @https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Visceral Pain Associated with GI Disorders Introduction
Executive Summary of Visceral Pain Associated with GI Disorders
Disease Background and Overview
Visceral Pain Associated with GI Disorders Epidemiology and patient population
Visceral Pain Associated with GI Disorders Emerging Therapies
Visceral Pain Associated with GI Disorders Market Outlook
Visceral Pain Associated with GI Disorders Market Access and Reimbursement of Therapies
Visceral Pain Associated with GI Disorders Market Drivers
Visceral Pain Associated with GI Disorders Market Barriers
Appendix
Visceral Pain Associated with GI Disorders Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the Visceral Pain Associated with GI Disorders Market Outlook report @
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports
Visceral Pain Associated with GI Disorders Epidemiology Forecast
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Visceral Pain Associated with GI Disorders Pipeline Forecast
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Visceral Pain Associated with GI Disorders Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies-AstraZeneca, Roche here
News-ID: 3154718 • Views: …
More Releases from DelveInsight Business Research LLP

Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…

Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…

DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…

Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Visceral
Innovative NHE3 Inhibitor Advances Visceral Pain Treatment Industry Trends Gaini …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Visceral Pain Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for visceral pain has seen a significant rise in the past few years. The prediction is that it will increase from $13.84 billion in 2024 to $14.87 billion in 2025, with a…
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expans …
The Visceral Pain Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Visceral Pain Market Size During the Forecast Period?
There has been a significant expansion in the size of the visceral pain market in past years. The market is projected to increase…
Visceral Leishmaniasis Market Share, Size, Trends and Global Forecast
The Visceral Leishmaniasis Treatments Market Is Set To Grow At An Estimated CAGR Of 6.6% From 2025 To 2034, Rising From $580 Million In 2024 To $1.1 Billion By 2034.
On April 15, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Visceral Leishmaniasis market goods. The market study excludes key regions that are accelerating marketization. This…
Key Influencer in the Visceral Pain Market 2025: Notable Surge In Buprenorphine …
What market dynamics are playing a key role in accelerating the growth of the visceral pain market?
The visceral pain market's growth is anticipated to be powered by an increasing need for analgesics. These pain relievers work by reducing or inhibiting the brain's perception of pain signals, providing relief from visceral pain by affecting the nervous system and controlling pain signals from the internal organs. The New England Journal of Medicine,…
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expans …
What Are the Projections for the Size and Growth Rate of the Visceral Pain Market?
Over the past few years, significant expansion has occurred in the visceral pain market. The projection is for it to escalate from a value of $13.84 billion in 2024 to a value of $14.87 billion in 2025, a compound annual growth rate (CAGR) of 7.5%. The surge during the historical growth cycle has been driven by…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…